MedPath

Role of Vaskadikwath in Non Proliferative Diabetic Retinopathy

Phase 2
Not yet recruiting
Conditions
Health Condition 1: H350- Background retinopathy and retinalvascular changesHealth Condition 2: H350- Background retinopathy and retinalvascular changesHealth Condition 3: H350- Background retinopathy and retinalvascular changes
Registration Number
CTRI/2023/03/051044
Lead Sponsor
Government Ayurvedic College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients type2 Non Insulin Dependent Diabetes with or without visual disturbance but detectable opthalmosope features of Diabetic Retinopathy with blood level FBS 126 to 220mg/dl or PPBS 170 to 330mg/dl with ongoing treatment

Early stage of NPDR

Exclusion Criteria

Patients who are extremely debilitating and those who are not withstand treatment procedure

High risk Diabetic Retinopathy or those requiring emergency intervention

Patients of Diabetic Retinopathy with media opacities like cataract vitreous degeneration etc with interfere with opthalmosopical finding

Patients having other ocular like glaucoma High myopia

Hypertensive Retinopathy and Diabetic Retinopathy associated with pregnancy

Patients who BCVA is less than 6/60

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of visionTimepoint: 60days
Secondary Outcome Measures
NameTimeMethod
Improvement of vision <br/ ><br>Timepoint: 30days
© Copyright 2025. All Rights Reserved by MedPath